AML PLATFORM - AN OVERVIEW

Despite achieving a complete response with best induction therapy, nominal residual disorder normally persists, necessitating consolidation therapy to mitigate the risk of relapse by eliminating residual illness. In individuals that have been given seven+three induction therapy, consolidation therapy is initiated with superior-dose cytarabine, als